Cleveland BioLabs
CBLI
#9801
Rank
$49.06 M
Marketcap
$3.17
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Market capitalization of Cleveland BioLabs (CBLI)

Last known market cap: $49.06 Million USD

As of December 2025 Cleveland BioLabs has a market cap of $49.06 Million USD. This makes Cleveland BioLabs the world's 9801th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cleveland BioLabs from 2006 to 2022

End of year Market Cap

Year Marketcap Change
2022$49.06 M0%
2021$49.06 M9.27%
2020$44.9 M560.24%
2019$6.8 M-40.4%
2018$11.41 M-74.77%
2017$45.23 M189.91%
2016$15.6 M-59.31%
2015$38.34 M135.37%
2014$16.29 M-69.18%
2013$52.86 M-11.14%
2012$59.49 M-41.42%
2011$0.10 B-51.42%
2010$0.20 B212.66%
2009$66.87 M129.24%
2008$29.17 M-74.3%
2007$0.11 B90.44%
2006$59.6 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
$20.9 M-57.40%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
$1.07 B 2,083.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$183.16 B 373,196.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$254.10 B 517,763.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
$105.75 B 215,431.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$119.36 B 243,156.01%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
$98.04 B 199,706.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
$16.44 M-66.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$909.44 B 1,853,336.59%๐Ÿ‡บ๐Ÿ‡ธ USA